Capital Asset Advisory Services’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
ACM
KGAMU
Capital Asset Advisory Services's CDLX Position: Q1 2021 in Review
Capital Asset Advisory Services sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 13 shares — an estimated $18K sold.
Capital Asset Advisory Services first reported a position in CDLX in Q4 2020 and held it in 1 quarter. The position peaked at $18K in Q4 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.
- Capital Asset Advisory Services reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
- Capital Asset Advisory Services sold 13 Cardlytics shares in Q1 2021, an estimated $18K.
- Capital Asset Advisory Services first reported a position in Cardlytics in Q4 2020 and held it in 1 quarter.
- Capital Asset Advisory Services's Cardlytics position peaked at $18K in Q4 2020.
- 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.
Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.